Brief: ANI Pharmaceuticals Announces FDA Approval And Commercialization Of Two ANDAs With CGT Exclusivity
15/05/2023 11:54
May 15 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS ANNOUNCES FDA APPROVAL AND
COMMERCIALIZATION
OF TWO ANDAS WITH CGT EXCLUSIVITY
Source text for Eikon: ID:nBw4ZlwGga
Further company coverage: ANIP.O
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma